We are live on ! Find out more
FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
-$227M
Cap. Flow
-$69M
Cap. Flow %
-4.99%
Top 10 Hldgs %
65.28%
Holding
52
New
8
Increased
7
Reduced
4
Closed
3

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
+$21M
2
ELVN icon
Enliven Therapeutics
ELVN
+$16.9M
3
BBIO icon
BridgeBio Pharma
BBIO
+$13.7M
4
MGNX icon
MacroGenics
MGNX
+$10.3M
5
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$8.34M

Top Sells

1
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$143M
2
ALLK
Allakos
ALLK
+$23.5M
3
REPL icon
Replimune Group
REPL
+$5.82M
4
KRYS icon
Krystal Biotech
KRYS
+$4.27M
5
EPIX
ESSA Pharma
EPIX
+$1.52M

Sector Composition

1 Healthcare 99.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLVX
1
DELISTED
HilleVax
HLVX
$162M 11.71%
9,781,472
+23,113
+0.2% +$370K
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.63B
$126M 9.09%
9,341,551
– –
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$101M 7.28%
4,345,559
– –
ARQT icon
4
Arcutis Biotherapeutics
ARQT
$3.47B
$95.5M 6.92%
8,684,232
– –
MIRM icon
5
Mirum Pharmaceuticals
MIRM
$7.16B
$92.7M 6.71%
3,860,107
– –
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$2.01B
$78.3M 5.67%
3,708,838
– –
KRYS icon
7
Krystal Biotech
KRYS
$10.1B
$75.7M 5.48%
945,407
-54,330
-5% -$4.27M
PHAT icon
8
Phathom Pharmaceuticals
PHAT
$875M
$60M 4.35%
8,407,152
– –
VRNA
9
DELISTED
Verona Pharma
VRNA
$59.1M 4.28%
2,944,349
+128,629
+5% +$2.78M
PCVX icon
10
Vaxcyte
PCVX
$8.09B
$52.4M 3.79%
1,397,405
– –
RYTM icon
11
Rhythm Pharmaceuticals
RYTM
$7.28B
$38.6M 2.8%
2,164,739
+270,739
+14% +$6.8M
KALV
12
DELISTED
KalVista Pharmaceuticals
KALV
$25.5M 1.84%
3,238,859
– –
COGT icon
13
Cogent Biosciences
COGT
$6.48B
$23.3M 1.69%
2,159,154
+50,000
+2% +$640K
ALPN
14
DELISTED
Alpine Immune Sciences Inc
ALPN
$23.1M 1.67%
2,985,757
– –
TYRA icon
15
Tyra Biosciences
TYRA
$1.88B
$22.8M 1.65%
1,421,310
+93,645
+7% +$1.11M
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$8.88B
$22.7M 1.65%
1,414,823
– –
TARS icon
17
Tarsus Pharmaceuticals
TARS
$2.52B
$22.5M 1.63%
1,787,527
– –
THRX
18
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$20M 1.45%
2,248,194
+850,000
+61% +$8.34M
ANAB icon
19
AnaptysBio
ANAB
$1.6B
$19.6M 1.42%
899,700
– –
BBIO icon
20
BridgeBio Pharma
BBIO
$15.7B
$19.4M 1.41%
+1,171,650
New +$13.7M
RVMD icon
21
Revolution Medicines
RVMD
$38.1B
$18.5M 1.34%
+854,484
New +$21M
ELVN icon
22
Enliven Therapeutics
ELVN
$3.63B
$18.2M 1.32%
+830,983
New +$16.9M
ACAD icon
23
Acadia Pharmaceuticals
ACAD
$4.39B
$16.1M 1.17%
857,338
– –
GRTS
24
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$14.4M 1.04%
5,162,348
– –
MRUS
25
DELISTED
Merus
MRUS
$13.7M 0.99%
746,479
– –
1
2 3

Similar funds

GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return